Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study
evidence
Supports the first human administration of dasatinib plus quercetin, its open-label uncontrolled design and its physical-function rather than pulmonary-function findings. V55 verification basis: not retrieved; the fourteen-patient figure is recalled.
A evidence is not a place. Drawing it on a map would assert something about the world that no stored fact supports.
Evidence · 0
This object cites no evidence.
Timeline
No dated observations are stored for this object. Atlas shows what was observed and when — it does not infer a history.
Connections · 0
Assembled narrative · 0
This object does not clear the publishing floor: an assembled narrative needs a description and at least one cited piece of evidence.
Observed changes · 0
No public Signals are attached to this object. Signals show what changed and when it was observed — never a direction or a rank.
Actions
/atlas?object=EVIDENCE_EV_JUSTICE_IPF_2019